The editor's roundtable: Implantable cardioverter-defibrillators in primary prevention of sudden cardiac death and disparity-related barriers to implementation

Am J Cardiol. 2011 Feb 15;107(4):583-90. doi: 10.1016/j.amjcard.2010.10.003.

Authors

Vincent E Friedewald¹, Gregg C Fonarow, Brian Olshansky, Clyde W Yancy, William C Roberts

Affiliation

¹ Department of Internal Medicine, The University of Texas Medical School at Houston, USA. vfriedew@nd.edu

PMID: 21295175
DOI: 10.1016/j.amjcard.2010.10.003

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anti-Arrhythmia Agents / therapeutic use
Death, Sudden, Cardiac / prevention & control*
Defibrillators, Implantable*
Education, Medical, Continuing / organization & administration
Heart Failure / diagnosis
Heart Failure / therapy*
Humans
Primary Prevention* / methods
Risk Assessment
Risk Factors
Treatment Outcome
Ventricular Dysfunction, Left / therapy*

Substances

Anti-Arrhythmia Agents